Similarly, it has been reported that SS18-SSX fusion genes are capable of transforming cells and knockdown of SS18-SSX expression can greatly reduce viability of synovial sarcoma cells, as determined by colony formation assays [48]. The gene discussed is SSX2; the disease is synovial sarcoma.